lte4 การใช้

• The eoxins are 14, 15-analogs of LTA4, LTC4, LTD4, and LTE4.
• Therefore, measurements of LTE4, especially in the urine, are commonly monitored in clinical research studies.
• It is formed from the sequential conversion of LTC4 to LTD4 and then to LTE4, which is the final and most stable cysteinyl leukotriene.
• The Glu and Gly residues of LTC4 may be removed step-wise by gamma-glutamyltransferase and a dipeptidase to form sequentially LTD4 and LTE4.
• Montelukast, Zafirlukast, and Pranlukast are receptor antagonists for the Cysteinyl leukotriene receptor 1 which contributes to mediating the actions of LTC4, LTD4, and LTE4.
• By comparison, the stimulating potencies of these CysLTs for CysLTR1 is LTD4 > LTC4 > LTE4 with LTD4 showing 10-fold greater potency on CysLTR1 than CysLTR2.
• Studies have suggested that LTE4 works through its own distinct receptor, and although one has not yet been discovered, research is ongoing to isolate and characterize an LTE4-specific receptor.
• Studies have suggested that LTE4 works through its own distinct receptor, and although one has not yet been discovered, research is ongoing to isolate and characterize an LTE4-specific receptor.
• CYSLTR2, by binding these cysteinyl LTs ( CysLTs; viz, LTC4, LTD4, and to a much lesser extent, LTE4 ) contributes to mediating various allergic and hypersensitivity reactions in humans.
• Compared to the short half lives of LTC4 and LTD4, LTE4 is relatively stable and accumulates in breath condensation, in plasma, and in urine, making it the dominant cysteinyl leukotriene detected in biologic fluids.
• Furthermore, blockers of LTC4, LTD4, and LTE4 synthesis ( i . e . ALOX5 inhibitors ) as well as of LTC4 and LTD4 receptor antagonists have proven inferior to corticosteroids as single drug therapy for persistent asthma, particularly in patients with airway obstruction.
• Other studies on model cells for allergy have defined GPR17 ( also termed the uracil nucleotide / cysteinyl leukotriene receptor ) as a receptor not only uracil nucleotides but also for CysLTs, with CysLTs having the following potencies LTD4 > LTC4 > LTE4 in stimulating GPR17-bearing cells.
• Increased production and excretion of LTE4 has been linked to several respiratory diseases, and urinary LTE4 levels are increased during severe asthma attacks and are especially high in people with aspirin-induced asthma, also known as Samter s Triad or aspirin-exacerbated respiratory disease ( AERD ).
• Increased production and excretion of LTE4 has been linked to several respiratory diseases, and urinary LTE4 levels are increased during severe asthma attacks and are especially high in people with aspirin-induced asthma, also known as Samter s Triad or aspirin-exacerbated respiratory disease ( AERD ).
• Acting through these G proteins and their subunits, ligand-bound CysLTR1 activates a series of pathways that lead to cell function ( see Gq alpha subunit # function and Ga subunit # function for details ); the order of potency of the cysLTs in stimulating CysLTR2 is LTD4 = LTC4 > LTE4 with LTE4 probably lacking sufficient potency to have much activity that operates through CysLTR1 in vivo.
• Acting through these G proteins and their subunits, ligand-bound CysLTR1 activates a series of pathways that lead to cell function ( see Gq alpha subunit # function and Ga subunit # function for details ); the order of potency of the cysLTs in stimulating CysLTR2 is LTD4 = LTC4 > LTE4 with LTE4 probably lacking sufficient potency to have much activity that operates through CysLTR1 in vivo.
• In addition to CysLTR1, GPR99 ( also termed the oxoglutarate receptor or, sometimes, CysLTR3 ) appears to be an important receptor for CysLTs, particularly for LTE4 : the CystLTs show relative potencies of LTE4 > LTC4 > LTD4 in stimulating GPR99-bearing cells and GPR99-deficient mice exhibit a dose-dependent loss of vascular permeability responses in skin to LTE4 but not to LTC4 or LTD4.
• In addition to CysLTR1, GPR99 ( also termed the oxoglutarate receptor or, sometimes, CysLTR3 ) appears to be an important receptor for CysLTs, particularly for LTE4 : the CystLTs show relative potencies of LTE4 > LTC4 > LTD4 in stimulating GPR99-bearing cells and GPR99-deficient mice exhibit a dose-dependent loss of vascular permeability responses in skin to LTE4 but not to LTC4 or LTD4.
• In addition to CysLTR1, GPR99 ( also termed the oxoglutarate receptor or, sometimes, CysLTR3 ) appears to be an important receptor for CysLTs, particularly for LTE4 : the CystLTs show relative potencies of LTE4 > LTC4 > LTD4 in stimulating GPR99-bearing cells and GPR99-deficient mice exhibit a dose-dependent loss of vascular permeability responses in skin to LTE4 but not to LTC4 or LTD4.
• LTC4, LTD4, and LTE4 contribute to allergic airways reactions such as asthma, certain non-allergic hypersensitivity airways reactions, and other lung diseases involving bronchoconstriction by contracting these airways and promoting in these airways inflammation, micro-vascular permeability, and mucus secretion; they likewise contribute to various allergic and non-allergic reactions involving rhinitis, conjunctivitis, and urticaria ( see LTC4, LTD4, and LTE4 ).